Financial News
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
October 29, 2024 at 06:55 AM EDT
It is a critical quarterly report for Pfizer, which is grappling with a proxy battle waged by the activist investor Starboard Value.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
